Dr. Howard Smith Oncall

  Vidcast:  https://youtu.be/06uzDxH7z6U   Hospitalized CoVid patients are 28% less likely to die of the disease if they are taking fluoxetine, the selective serotonin reuptake inhibitor, SSRI, best known as Prozac and prescribed for clinical depression.  A study from UC-San Francisco analyzed the data from 83,584 patients diagnosed with CoVid of whom 3,401 were on an SSRI.   The researchers comment that the beneficial effects of SSRIs are less dramatic compared with the medications already in use to treat hospitalized CoVid patients such as antibody cocktails, remdesivir, dexamethasone, and tocilizumab.  It is possible, though, that these anti-depressive medications may yet play a role in the treatment of hospitalized CoVid patients by enhancing the effects of these other medications.   https://jamanetwork.com/journals/jamanetworkopen/fullarticle/2786136   #CoVid #ssri #antidepressives #prozac #hospitalization #death